Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland · Delayed Price · Currency is CHF 52.60
-0.20 (-0.38%)
Mar 12, 2026, 5:30 PM CET
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 649 million as of March 12, 2026. Its market cap has increased by 17.33% in one year.
Market Cap
649.00M
Enterprise Value
578.42M
Revenue
232.38M
Ranking
n/a
PE Ratio
16.80
Stock Price
52.60
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 533.29M to 649.00M, an increase of 21.70%. That is a compound annual growth rate of 0.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 649.00M | -3.44% |
| Dec 30, 2025 | 672.13M | 34.10% |
| Dec 30, 2024 | 501.21M | 18.52% |
| Dec 29, 2023 | 422.90M | -22.52% |
| Dec 30, 2022 | 545.84M | 12.62% |
| Dec 30, 2021 | 484.67M | -15.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 978.36M |
| Newron Pharmaceuticals | 363.28M |
| Santhera Pharmaceuticals Holding AG | 237.31M |
| Xlife Sciences AG | 140.73M |
| Molecular Partners AG | 140.25M |
| BioVersys AG | 135.09M |
| EvoNext Holdings | 6.35M |
| Addex Therapeutics | 5.25M |